NEAUVIA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10962
Neauvia Stimulate Man
In stock
Volume
1 x 1 mL
Laboratory
Matex Lab S.P.A
Origin
イタリア
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Neauvia Stimulate Man is a biodegradable, PEG cross-linked hyaluronic acid filler enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy, developed to restore lost volume of the soft tissue and resorbed over time. It is placed in the subdermis and over the periosteum, which is what allows it to be laid onto bone for structural support. At 28 mg/mL of hyaluronic acid with a medium to high extrusion force, it is the most concentrated reference in the Stimulate line and, like every filler in the range, it is enriched with glycine and L-proline. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market.
主なメリット： Neauvia Stimulate Man
- 28 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- The most concentrated reference in the Stimulate line
- One of the only PEG-HA plus CaHA fillers on the market
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- Can be laid onto bone to provide structural support and lift
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- No crosslinker residuals remain after complete degradation
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
適応と専門的な使用
主な適応
- Restoration of lost volume of the soft tissue
専門的な使用
For professional use. Neauvia Stimulate Man is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Supraperiosteal placement of this kind demands advanced anatomical knowledge of the injection site and its surroundings. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices.
施術部位
- Face
対象となる患者
Suitable for adult patients presenting with age-related volume loss of the soft tissue, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
作用の仕組み： Neauvia Stimulate Man
Stimulate Man combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. The PEGDE cross-linking gives the hydrogel high conformational flexibility, so the gel modifies shape without structural damage under the push and pull of internal movement and external force, while retaining its form once placed. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance, giving better control of the hydrogel's swelling capacity in the post-implant phase. The gel is a temporary filling, with a 6 month degradation average time.
Allparaで注文する理由
Allparaは、正規品で検証済みの NEAUVIA 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。
よくある質問
How does Neauvia Stimulate Man differ from Neauvia Stimulate?
Concentration. Neauvia Stimulate Man carries 28 mg/mL hyaluronic acid against 26 mg/mL for Stimulate. Both are enriched with calcium hydroxyapatite, share a medium to high extrusion force, and are placed in the subdermis or over the periosteum with 21G or 22G needles or cannulas.
Why does Neauvia Stimulate Man contain calcium hydroxyapatite?
It is what distinguishes the Stimulate line, the only PEG-HA plus CaHA fillers on the market. A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue.
その他の製品： Matex Lab S.P.A
Clinic alternatives
/ Recently viewed
Pick up where you left off
Neauvia Stimulate Man
In stock
CE Marked
Neauvia Stimulate Man is a biodegradable, PEG cross-linked hyaluronic acid filler enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy, developed to restore lost volume of the soft tissue and resorbed over time. It is placed in the subdermis and over the periosteum, which is what allows it to be laid onto bone for structural support. At 28 mg/mL of hyaluronic acid with a medium to high extrusion force, it is the most concentrated reference in the Stimulate line and, like every filler in the range, it is enriched with glycine and L-proline. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market.
主なメリット： Neauvia Stimulate Man
- 28 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- The most concentrated reference in the Stimulate line
- One of the only PEG-HA plus CaHA fillers on the market
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- Can be laid onto bone to provide structural support and lift
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- No crosslinker residuals remain after complete degradation
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
適応と専門的な使用
主な適応
- Restoration of lost volume of the soft tissue
専門的な使用
For professional use. Neauvia Stimulate Man is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Supraperiosteal placement of this kind demands advanced anatomical knowledge of the injection site and its surroundings. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices.
施術部位
- Face
対象となる患者
Suitable for adult patients presenting with age-related volume loss of the soft tissue, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
作用の仕組み： Neauvia Stimulate Man
Stimulate Man combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. The PEGDE cross-linking gives the hydrogel high conformational flexibility, so the gel modifies shape without structural damage under the push and pull of internal movement and external force, while retaining its form once placed. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance, giving better control of the hydrogel's swelling capacity in the post-implant phase. The gel is a temporary filling, with a 6 month degradation average time.
Allparaで注文する理由
Allparaは、正規品で検証済みの NEAUVIA 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。
よくある質問
How does Neauvia Stimulate Man differ from Neauvia Stimulate?
Concentration. Neauvia Stimulate Man carries 28 mg/mL hyaluronic acid against 26 mg/mL for Stimulate. Both are enriched with calcium hydroxyapatite, share a medium to high extrusion force, and are placed in the subdermis or over the periosteum with 21G or 22G needles or cannulas.
Why does Neauvia Stimulate Man contain calcium hydroxyapatite?
It is what distinguishes the Stimulate line, the only PEG-HA plus CaHA fillers on the market. A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue.
その他の製品： Matex Lab S.P.A
ラボを見る →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.